1. Home
  2. AYTU vs OP Comparison

AYTU vs OP Comparison

Compare AYTU & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • OP
  • Stock Information
  • Founded
  • AYTU N/A
  • OP 2021
  • Country
  • AYTU United States
  • OP Greece
  • Employees
  • AYTU N/A
  • OP N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • OP
  • Sector
  • AYTU Health Care
  • OP
  • Exchange
  • AYTU Nasdaq
  • OP Nasdaq
  • Market Cap
  • AYTU 9.8M
  • OP 10.5M
  • IPO Year
  • AYTU N/A
  • OP N/A
  • Fundamental
  • Price
  • AYTU $1.38
  • OP $1.09
  • Analyst Decision
  • AYTU
  • OP
  • Analyst Count
  • AYTU 0
  • OP 0
  • Target Price
  • AYTU N/A
  • OP N/A
  • AVG Volume (30 Days)
  • AYTU 37.1K
  • OP 20.6K
  • Earning Date
  • AYTU 02-12-2025
  • OP 12-31-2024
  • Dividend Yield
  • AYTU N/A
  • OP N/A
  • EPS Growth
  • AYTU N/A
  • OP N/A
  • EPS
  • AYTU N/A
  • OP N/A
  • Revenue
  • AYTU $79,759,000.00
  • OP $22,098,000.00
  • Revenue This Year
  • AYTU N/A
  • OP N/A
  • Revenue Next Year
  • AYTU N/A
  • OP N/A
  • P/E Ratio
  • AYTU N/A
  • OP N/A
  • Revenue Growth
  • AYTU N/A
  • OP 9.82
  • 52 Week Low
  • AYTU $1.30
  • OP $1.04
  • 52 Week High
  • AYTU $3.45
  • OP $3.15
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 33.90
  • OP 17.26
  • Support Level
  • AYTU $1.30
  • OP $1.04
  • Resistance Level
  • AYTU $1.47
  • OP $1.50
  • Average True Range (ATR)
  • AYTU 0.12
  • OP 0.06
  • MACD
  • AYTU -0.01
  • OP -0.03
  • Stochastic Oscillator
  • AYTU 17.78
  • OP 11.63

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.

Share on Social Networks: